Evogene Ltd. EVGN
Set alert
0.36 USD -0.01 -3.63%
At close · Nov 2
0.37 +0.01 +3.77%
After hours · Nov 2, 6:57 PM ET
0.36 Day range 0.3742
0.35 52-week range 1.28
- YTD
- -67.18%
- 1 year
- -71.35%
- Open
- 0.3669
- Prev close
- 0.3746
- Mkt cap
- 4.90M
- Vol
- 25.39K
- Avg vol
- 1.42M
- EPS
- -1.50
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.36
- High
- 0.3742
- Forward P/E
- -0.39
- Beta
- 1.08
- Short ratio
- 0.04
- Inst. own
- 11.12%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.87
- 200-d avg
- 4.76
- 1y target
- 8.13
3M chart
Signals (9)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 2, 2026 | 2 months ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 20, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 18, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 3 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
Financial health
Altman Z-Score
-32.49 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -1.0×
FY 2016 5y median -1.1× FY 2025
P/S 2.2×
FY 2016 5y median 12.9× FY 2025
P/B -106×
FY 2016 5y median 1.0× FY 2025
P/FCF -0.6×
FY 2016 5y median -1.2× FY 2025
EV/EBITDA 0.2×
FY 2016 5y median -0.6× FY 2025
EV/Sales -0.5×
FY 2016 5y median 7.0× FY 2025
FCF Yield -157.4%
FY 2016 5y median -86.1% FY 2025
Profitability
Gross Margin -6.3%
FY 2016 5y median 45.7% FY 2025
Operating Margin -364.2%
FY 2016 5y median -745.5% FY 2025
Net Margin -220.2%
FY 2016 5y median -800.8% FY 2025
ROE 10347.6%
FY 2016 5y median -51.8% FY 2025
ROIC -81.0%
FY 2016 5y median -52.4% FY 2025
ROA -42.3%
FY 2016 5y median -42.3% FY 2025
Growth (YoY)
Revenue -30.9%
FY 2016 FY 2025
Operating Income 25.4%
FY 2016 FY 2025
EPS (diluted) 62.6%
FY 2016 FY 2025
Free Cash Flow 32.9%
FY 2016 FY 2025
Financial Health
Current Ratio 4.5×
FY 2016 5y median 5.0× FY 2025
Quick Ratio 4.5×
FY 2016 5y median 5.0× FY 2025
Debt / Equity -26.8×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.9×
FY 2016 5y median 0.6× FY 2025
Interest Coverage -7.4×
FY 2016 5y median -112× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
